Scientific Advisory Board
The World Trade Group Scientific Advisory Board is a group of recognized experts and practionners from the life science industry.
The board meets a few times a year, either as a group or on a one-to-one basis to help drive the programmes to ensure it reflects the key industry concerns.
The board continually help review and mould our conference programmes, drawing upon their wealth of experience to advise on current industry developments and potential speakers, with many taking part in the event themselves.
Current Advisory Board Members Include:
 |
Dr. Lee Babiss
Head of Global Pharma Research,
Hoffmann-La Roche, Ltd, Switzerland |
 |
Dr. David De Graaf
Director of Systems Biology
Pfizer Research Technology Center (RTC)USA |
 |
Dr. Fadel Hamed
Head of Operational Excellence
Genentech Product Operations, USA |
 |
Dr. Neil Weir
Senior Vice President, Global Research, UCB Celltech
UK |
 |
Dr. Orest Hurko
Assistant Vice President for Clinical Discovery, Translational Research
Wyeth
USA |
 |
Prof. Ian Wilson
Senior Principal Scientist
AstraZeneca
UK |
 |
Robert Repetto
Director
Global New Technology and Innovation, Manufacturing Sciences & Technology, Wyeth Biotech, & Head of Disposables Technologies Task Force, Parenteral Drug Association – PDA
USA |
 |
Dr. Jinghai J. Xu
Director of Automated Biotechnology
Merck & Co
USA |
Application for membership
We are continually seeking new members to join our advisory boards. If you would like more information or would like to help drive the conference programme by becoming an Advisory Board member, please contact:
Dora Walsh
dora.walsh@wtgevents.com
Senior Analyst, Life Science Division,
World Trade Group
T: +44 (0) 20 7202 7695
Please note acceptance onto the advisory board is not automatic and each enquiry will be judged on its own merit. The Advisory Board reserves the right to reject applications based on incomplete or unverifiable information.